Atezolizumab and Bevacizumab in Rare Solid Tumors
Conditions: Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasms of Respiratory and Intrathoracic Organs Interventions: Drug: Atezolizumab; Drug: Bevacizumab; Behavioral: Phone Call Sponsors: M.D. Anderson Cancer Center; Genentech, Inc. Not yet recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer & Oncology | Oral Cancer | Oral Cavity Cancer | Pharyngeal Cancer | Respiratory Medicine